Incyte Corporation (INCY)

Incyte Market Cap

Incyte has a market cap or net worth of $22.86 billion as of October 9, 2026. It is the 1,072nd most valuable company in the world and the 438th biggest in the United States. Its market cap has increased by 37.12% in one year.

• Market Cap: 22.86B
• Enterprise Value: 18.36B
• 1-Year Change: 37.12%
• Global Rank: #1,072
• Country Rank: #438 United States
• Category: Large-Cap

Market Cap Chart

Chart

Since December 1, 1998, Incyte's market cap has increased from $887.90M to $22.86B, an increase of 2,474.87%. That is a compound annual growth rate of 12.36%.

Market Cap History

Date	Market Cap	% Change
Oct 9, 2026	22.86B	17.90%
Dec 31, 2025	19.39B	45.73%
Dec 31, 2024	13.31B	-5.44%
Dec 29, 2023	14.07B	-21.25%
Dec 30, 2022	17.87B	10.21%
Dec 31, 2021	16.21B	-14.88%
Dec 31, 2020	19.05B	1.27%
Dec 31, 2019	18.81B	38.99%
Dec 31, 2018	13.53B	-32.29%
Dec 29, 2017	19.99B	5.81%
Dec 30, 2016	18.89B	-6.36%
Dec 31, 2015	20.17B	63.32%
Dec 31, 2014	12.35B	51.41%
Dec 31, 2013	8.16B	274.30%
Dec 31, 2012	2.18B	14.96%
Dec 30, 2011	1.90B	-7.01%
Dec 31, 2010	2.04B	88.80%
Dec 31, 2009	1.08B	193.21%
Dec 31, 2008	368.30M	-56.50%
Dec 31, 2007	846.70M	72.90%
Dec 29, 2006	489.70M	9.92%
Dec 30, 2005	445.50M	-39.62%
Dec 31, 2004	737.80M	48.87%
Dec 31, 2003	495.60M	59.97%
Dec 31, 2002	309.80M	-76.00%

View and export this data all the way back to 1998. Sign Up Today.

Data Source: Nasdaq Data Link Last updated: Oct 9, 2026

Market cap data is provided by Nasdaq Data Link. The current market cap updates continuously throughout the trading day, while the historical market cap is updated daily after market close.

Update frequency:

Daily

Last checked:

Oct 11, 2026

Data Sources Report a data error

Related Stocks

Company	Market Cap
BeOne Medicines AG	39.81B
Royalty Pharma	32.32B
Alnylam Pharmaceuticals	30.04B
Roivant Sciences	24.71B
BioNTech SE	23.13B
Insmed	21.94B
Genmab	21.09B
Ascendis Pharma	14.62B